home / stock / nyxh / nyxh quote
Last: | $9.08 |
---|---|
Change Percent: | -0.22% |
Open: | $8.6501 |
Close: | $9.10 |
High: | $9.08 |
Low: | $8.6501 |
Volume: | 668 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$9.08 | $8.6501 | $9.1 | $9.08 | $8.6501 | 668 | 07-22-2024 |
$9.1 | $9.067 | $9.1 | $9.25 | $8.955 | 2,056 | 07-19-2024 |
$9.107 | $9.3858 | $9.107 | $9.3858 | $8.98 | 3,989 | 07-18-2024 |
$9.0001 | $9.3521 | $9.0001 | $9.4 | $8.8201 | 12,531 | 07-17-2024 |
$9.4 | $9.22 | $9.4 | $9.41 | $9.22 | 9,664 | 07-16-2024 |
$9.3 | $9.51 | $9.3 | $9.51 | $8.89 | 6,018 | 07-15-2024 |
$9.44 | $8.59 | $9.44 | $9.5 | $8.59 | 8,788 | 07-12-2024 |
$8.56 | $8.94 | $8.56 | $8.94 | $8.53 | 4,561 | 07-11-2024 |
$8.75 | $8.91 | $8.75 | $8.95 | $8.47 | 15,245 | 07-10-2024 |
$8.78 | $8.6 | $8.78 | $8.88 | $8.3 | 19,185 | 07-09-2024 |
$8.47 | $8.36 | $8.47 | $8.53 | $8.36 | 13,846 | 07-08-2024 |
$7.8228 | $7.56 | $7.8228 | $8.13 | $7.56 | 24,443 | 07-05-2024 |
$7.39 | $7.35 | $7.39 | $7.39 | $7.18 | 2,319 | 07-04-2024 |
$7.39 | $7.35 | $7.39 | $7.39 | $7.18 | 2,319 | 07-03-2024 |
$7.02 | $7.05 | $7.02 | $7.2807 | $6.76 | 11,206 | 07-02-2024 |
$7.03 | $7.4399 | $7.03 | $7.4399 | $6.97 | 18,905 | 07-01-2024 |
$6.97 | $7.15 | $6.97 | $7.15 | $6.93 | 5,167 | 06-28-2024 |
$6.8701 | $7.1 | $6.8701 | $7.14 | $6.855 | 10,142 | 06-27-2024 |
$6.87 | $7.54 | $6.87 | $7.8 | $6.87 | 81,875 | 06-26-2024 |
$7.9475 | $7.63 | $7.9475 | $8 | $7.5001 | 30,326 | 06-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Nyxoah Appoints Scott Holstine as Chief Commercial Officer Mont-Saint-Guibert, Belgium – July 15, 2024, 8:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the ...
REGULATED INFORMATION INSIDE INFORMATION Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank Mont-Saint-Guibert, Belgium – July 3, 2024, 12:30pm CET / 6:30am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (&...
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA Mont-Saint-Guibert (Belgium), July 1, 2024 , 8:00am CET / 2:00am ET – (“Nyxoah” or the “Company”), a medical technology company focused on the develop...